Procter & Gamble Aktie 963896 / US7427181091
156.63
USD
-0.41
USD
-0.26 %
29.07.2025
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Procter Gamble Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Procter & Gamble Co. | 2.32 | 3.83 | USD |
| 2023 | Procter & Gamble Co. | 2.43 | 3.68 | USD |
| 2022 | Procter & Gamble Co. | 2.45 | 3.52 | USD |
| 2021 | Procter & Gamble Co. | 2.40 | 3.24 | USD |
| 2020 | Procter & Gamble Co. | 2.53 | 3.03 | USD |
| 2019 | Procter & Gamble Co. | 2.64 | 2.90 | USD |
| 2018 | Procter & Gamble Co. | 3.57 | 2.79 | USD |
| 2017 | Procter & Gamble Co. | 3.10 | 2.70 | USD |
| 2016 | Procter & Gamble Co. | 3.14 | 2.66 | USD |
| 2015 | Procter & Gamble Co. | 3.32 | 2.59 | USD |
Gewinn je Aktie- Procter & Gamble
| 6.5 25 | 6.0 24 | 5.9 23 | 5.8 22 | 5.5 21 | 5.0 20 | 1.4 19 |
Umsatz je Aktie- Procter & Gamble
| 34.3 25 | 34.0 24 | 33.0 23 | 31.6 22 | 29.3 21 | 27.0 20 | 26.7 19 |
KGV- Procter & Gamble
| 24.5 25 | 27.4 24 | 25.7 23 | 24.8 22 | 24.5 21 | 24.1 20 | 76.6 19 |
Procter & Gamble Co.: Die Aktie (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | 6.51 | 6.02 | 5.90 | 5.81 | 5.50 | 4.96 | 1.43 |
| Gewinn je Aktie (unverwässert) | 6.67 | 6.18 | 6.07 | 6.00 | 5.69 | 5.13 | 1.45 |
| Gewinn je Aktie (verwässert) | 6.51 | 6.02 | 5.90 | 5.81 | 5.50 | 4.96 | 1.43 |
| Dividende je Aktie | 4.08 | 3.83 | 3.68 | 3.52 | 3.24 | 3.03 | 2.90 |
| Veränderung Dividende je Aktie in % | 6.47 | 4.02 | 4.48 | 8.66 | 7.05 | 4.52 | 4.00 |
| Gesamtdividendenausschüttung in Mio. | 9’872.00 | 9’312.00 | 8’999.00 | 8’770.00 | 8’263.00 | 7’789.00 | 7’498.00 |
Procter & Gamble Co.: Unternehmenskennzahlen (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 34.34 | 34.00 | 33.02 | 31.58 | 29.26 | 27.02 | 26.65 |
| KGV (Jahresendkurs, Gewinn unverwässert) | 24.48 | 27.40 | 25.72 | 24.77 | 24.53 | 24.10 | 76.62 |
| KGV (Jahresendkurs, Gewinn verwässert) | 24.48 | 27.40 | 25.72 | 24.77 | 24.53 | 24.10 | 76.62 |
| Dividendenrendite Jahresende in % | 2.56 | 2.32 | 2.43 | 2.45 | 2.40 | 2.53 | 2.64 |
| Eigenkapitalquote in % | 41.75 | 41.32 | 38.95 | 39.98 | 39.10 | 38.84 | 41.34 |
| Fremdkapitalquote in % | 58.25 | 58.68 | 61.05 | 60.02 | 60.90 | 61.16 | 58.66 |
Procter & Gamble Co.: GuV (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 84’284.00 | 84’039.00 | 82’006.00 | 80’187.00 | 76’118.00 | 70’950.00 | 67’684.00 |
| Umsatzveränderung in % | 0.29 | 2.48 | 2.27 | 5.35 | 7.28 | 4.83 | 1.27 |
| Bruttoergebnis vom Umsatz | 43’120.00 | 43’439.00 | 39’406.00 | 38’212.00 | 39’144.00 | 36’314.00 | 33’437.00 |
| Bruttoergebnisveränderung in % | -0.73 | 10.23 | 3.12 | -2.38 | 7.79 | 8.60 | 0.16 |
| Operatives Ergebnis | 20’451.00 | 20’198.00 | 18’357.00 | 17’913.00 | 18’592.00 | 16’392.00 | 14’512.00 |
| Veränderung Operatives Ergebnis in % | 1.25 | 10.03 | 2.48 | -3.65 | 13.42 | 12.95 | -1.83 |
| Ergebnis vor Steuern | 20’167.00 | 18’761.00 | 18’353.00 | 17’995.00 | 17’615.00 | 15’834.00 | 6’069.00 |
| Veränderung Ergebnis vor Steuern in % | 7.49 | 2.22 | 1.99 | 2.16 | 11.25 | 160.90 | -54.46 |
| Ergebnis nach Steuer | 15’974.00 | 14’879.00 | 14’653.00 | 14’742.00 | 14’306.00 | 13’027.00 | 3’897.00 |
| Veränderung Ergebnis nach Steuer in % | 7.36 | 1.54 | -0.60 | 3.05 | 9.82 | 234.28 | -60.03 |
Procter & Gamble Co.: Bilanz (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 72’947 | 71’811 | 73’764 | 70’354 | 72’653 | 73’822 | 67’516 |
| Langzeit Gesamtverbindlichk. je Aktie | - | 16.20 | 16.09 | 15.57 | 16.27 | 16.47 | 14.99 |
| Eigenkapital | 52’284 | 50’559 | 47’065 | 46’854 | 46’654 | 46’878 | 47’579 |
| Veränderung Eigenkapital in % | 5.65 | 7.68 | 0.46 | 0.52 | -0.25 | -1.39 | -9.86 |
| Bilanzsumme | 125’231 | 122’370 | 120’829 | 117’208 | 119’307 | 120’700 | 115’095 |
| Veränderung Bilanzsumme in % | 2.34 | 1.28 | 3.09 | -1.76 | -1.15 | 4.87 | -2.72 |
Procter & Gamble Co.: Sonstige Angaben (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 6.67 | 6.18 | 6.07 | 6.00 | 5.69 | 5.13 | 1.45 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 7.86 | 1.91 | 1.14 | 5.41 | 10.91 | 253.57 | -61.29 |
| Gewinn je Aktie (verwässert) | 6.51 | 6.02 | 5.90 | 5.81 | 5.50 | 4.96 | 1.43 |
| Veränderung Gewinn je Aktie (verwässert) in % | 8.12 | 2.04 | 1.61 | 5.56 | 10.86 | 246.69 | -61.01 |
| Anzahl Mitarbeiter | - | 108’000 | 107’000 | 106’000 | 101’000 | 99’000 | 97’000 |
| Veränderung Anzahl Mitarbeiter in % | - | 0.93 | 0.94 | 4.95 | 2.02 | 2.06 | 5.43 |
Procter & Gamble Co. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Procter & Gamble Co. | Quartalszahlen | 15.10.2025 |
| Procter & Gamble Co. | Quartalszahlen | 28.01.2026 |
| Procter & Gamble Co. | Quartalszahlen | 17.04.2026 |
| Procter & Gamble Co. | Quartalszahlen | 04.08.2026 |
Procter & Gamble Co. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q4 2025 Earnings Release | 29.07.2025 |
| Quartalszahlen | Q3 2025 Earnings Release | 24.04.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 22.01.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 18.10.2024 |
| Hauptversammlung | Annual General Meeting | 08.10.2024 |
| Quartalszahlen | Q4 2024 Earnings Release | 30.07.2024 |
| Quartalszahlen | Q3 2024 Earnings Release | 19.04.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 23.01.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 18.10.2023 |
| Hauptversammlung | Annual General Meeting | 10.10.2023 |
| Quartalszahlen | Q4 2023 Earnings Release | 28.07.2023 |
| Quartalszahlen | Q3 2023 Earnings Release | 21.04.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 19.01.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 19.10.2022 |
| Hauptversammlung | Annual General Meeting | 11.10.2022 |
| Quartalszahlen | Q4 2022 Earnings Release | 29.07.2022 |
| Quartalszahlen | Q3 2022 Earnings Release | 20.04.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 19.01.2022 |
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 97’000 | 99’000 | 101’000 | 106’000 | 107’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.70 | 0.72 | 0.75 | 0.76 | 0.77 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 22’473 | 27’987 | 23’091 | 21’653 | 22’648 |
| Summe Anlagevermögen | 92’622 | 92’713 | 96’216 | 95’555 | 98’181 |
| Summe Aktiva | 115’095 | 120’700 | 119’307 | 117’208 | 120’829 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 67’516 | 73’822 | 72’653 | 70’354 | 73’764 |
| Summe Eigenkapital | 47’579 | 46’878 | 46’654 | 46’854 | 47’065 |
| Summe Passiva | 115’095 | 120’700 | 119’307 | 117’208 | 120’829 |
Adresse
| 1 Procter & Gamble Plaza, 45202-3315 Cincinnati | |
| Telefon | +1 (513) 983-1100 |
| Fax | +1 (513) 983-4381 |
| URL | http://us.pg.com/ |
Management
|
Amy L. Chang
Independent Director |
|
Andre Schulten
Chief Financial Officer |
|
Ashley A. McEvoy
Independent Director |
|
Balaji Purushothaman
Chief Human Resources Officer |
|
Bertrand-Marc Allen
Independent Director |
|
Brett M. Biggs
Independent Director |
|
Christine M. McCarthy
Independent Director |
|
Christopher J. Kempczinski
Independent Director |
|
Craig Arnold
Independent Director |
|
Damon Jones
Chief Communications Officer |
|
Debra L. Lee
Independent Director |
|
Jennifer L. Davis
Chief Executive Officer-Health Care |
|
Joe Stegbauer
General Counsel, SVP-Corporate & Global Business |
|
John T. Chevalier
Investor Relations Contact |
|
Jon R. Moeller
Chairman, President & Chief Executive Officer |
|
Joseph Jimenez
Lead Independent Director |
|
Kirti Singh
Chief Analytics, Insights & Media Officer |
|
Kristine Decker
Chief Equality & Inclusion Officer |
|
Luc Reynaert
Chief Product Supply Officer |
|
Marc S. Pritchard
Chief Brand Officer |
|
Matthew W. Janzaruk
Chief Accounting Officer & Senior Vice President |
|
Mindy Sherwood
Chief Sales Officer & President-Global Walmart |
|
Monica J. Turner
President-North America |
|
Namrata P Patel
Senior Vice President-Product Supply |
|
Patricia Ann Woertz
Independent Director |
|
Philip J. Duncan
Chief Design Officer |
|
R. Alexandra Keith
Chief Executive Officer-Beauty |
|
Rajesh Subramaniam
Independent Director |
|
Robert Jones Portman
Independent Director |
|
Seth Cohen
Chief Information Officer |
|
Shailesh G. Jejurikar
Chief Operating Officer |
|
Sheila A. Bonini
Independent Director |
|
Susan Street Whaley
Secretary & Chief Legal Officer |
|
Terry J. Lundgren
Independent Director |
|
Victor Aguilar
Chief Research, Development & Innovation Officer |
|
Virginie Helias
Chief Sustainability Officer |